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Occasional Paper No. 05 - July 2004
 
Implementation of the Renal NSF in the 
North East and Cumbria 
Introduction 
English Public Health Observatories have as one as their remits supporting the implementation 
of the National Service Frameworks (NSFs).  This report provides a summary of a study that 
was set up in 2002 by the North East PHO to examine the implications of implementing the 
Renal NSF1.  Part 1 of the Renal NSF was published in January 20041, but the remaining parts 
are still being developed.   
 
It was anticipated that the 
North East & Cumbria would 
have well established and 
high quality renal services due 
to the work of an existing 
Regional Commissioning 
Group.   
 
In the study, consideration 
was given to progress in 
developing Renal Services in 
the North East & Cumbria and 
likely implications for this 
area.   This report identifies 
  
 key issues which influence the quality of care in renal 
disease that are likely to 
have implications for NHS 
commissioning and service 
delivery.  Findings are 
presented under the 
following headings: 
 
• Data collection; 
• Service planning and 
commissioning; 
• Staffing; 
• Care pathways; 
 
 • Patient access; and • Transplantation.   
 
The issues explored in this 
report are key aspects of 
service provision.  A number 
of these areas are directly 
related to the standards 
published in Part 1 of the 
Renal NSF.  
Recommendations are mainly 
focussed on the region, but 
some are applicable at 
national level. 
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 Summary of Recommendations • All Renal Units should be required to return data to the UK Renal 
Registry and this needs to be properly funded; 
• Strategic Health Authorities and PCTs in the North East & Cumbria 
need to ensure a longer term remit for the existing Regional 
Commissioning Group for renal services; 
• Staffing levels should be reviewed including consultants, junior 
doctors, nurse roles and the use of technicians; 
• Guidelines for screening and use of erythropoietin in primary care 
should be agreed and implemented.  Referral guidelines should be 
developed taking into account the resulting impact on outpatient 
services; 
• Pre-dialysis counselling should be provided by all Renal Units; 
• Surgical links to renal medicine for vascular access should be 
clearly defined in all Renal Units; 
• Access to renal replacement therapy and outpatient services 
should be improved in areas where access is currently poor; 
• Renal Units should identify problems with existing patient transport 
providers and work with patients to improve the service. 
• Access to and handling of donor organs needs to be improved; 
• Access to theatres for transplant surgery could be improved but 
this should be balanced with access by other emergency services. 
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Study Method 
 
This study was undertaken during 2003 before any parts of the Renal NSF were available.  The study 
had two parts as follows: 
 
• An examination of the availability, accuracy and completeness of data on renal disease; and 
• A qualitative consideration of the views of commissioners and providers of renal services in the 
North East & Cumbria on the likely key aspects of service provision required for the 
implementation of the Renal NSF.  
 
For the first part of the study, existence of the UK Renal Registry means that, with regard to renal 
replacement therapy (RRT) a comprehensive and standardised data set is already defined.  Data from 
the UK Renal Registry is used in this report to illustrate the provision and quality of renal services in the 
North East & Cumbria.  General issues of availability, accuracy and completeness of data are reported. 
 
The second part of the study was undertaken in two stages.  The first stage involved an examination of 
submissions to the Renal NSF process and discussions with three members of the Renal NSF External 
Reference Group to identify key issues of importance to the NSF.  These issues formed the basis of the 
semi-structured interviews used in the second stage and undertaken by Meryl Deane with at least one 
clinician from each of the four Renal Units in the North East & Cumbria and at least one representative 
of the Regional Commissioning Group.  Content analysis was used to interpret the interview findings and 
the common issues were further explored with reference to the literature. 
 
This report presents the findings from both parts of the study and reports key findings and 
recommendations in relation to both data collection and provision and commissioning and provision of 
renal services in the North East & Cumbria. 
 
 
Epidemiology of Renal Disease 
 
What is renal disease? 
 
Renal disease is disease of the kidney.  Kidney function is essential for life.  If the kidneys fail then the 
body is unable to excrete certain waste products, excess water and salts, and is unable to control the 
body’s acidity leading to death. 
 
Chronic renal failure (CRF) is a gradual and progressive loss of kidney function.  End stage renal failure 
(ESRF) is an irreversible, long-term condition in which the kidneys fail and renal replacement therapy 
(RRT) – treatment to augment or replace the function of the failing kidneys – is required to maintain life. 
 
Renal disease appears less common in the UK than in the USA, in 2001, for example: 
 
• Prevalence was 566 per million population in the UK2 compared to 1,403 per million population in 
the USA3; and  
• Incidence rate was 93 per million population in the UK2 compared to 336 per million population in 
the USA3. 
 
The acceptance rate onto renal replacement therapy (RRT) is a reflection of the incidence of end stage 
renal failure (ESRF).  In the UK, this has risen from 20 per million population in 1980 to 101 per million 
population in 20024.   
 
Prediction modelling by the UK Renal Registry suggests an increase in the numbers of patients on RRT 
for the next 20 years - probably to an annual incidence of about 100-110 per million population - when 
the numbers should stabilise.  Prevalence will therefore also increase. 
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Factors affecting the level of renal disease level in a population 
 
The level of renal disease in a population is influenced by a number of key factors in the population.  
The incidence of renal disease is higher in those of a South Asian and African Caribbean descent.  
Patients with high blood pressure and diabetes, which is increasing, also have a higher incidence of renal 
disease.  Patients who have had renal disease in the past are at higher risk of developing renal failure.  
The incidence of renal disease rises with increasing age, the incidence is thus higher in older 
populations. 
 
Population levels of renal disease appear lower in Europe than in the USA5,6,7,8 with the UK having a 
lower treatment rate than much of the rest of Europe.  The length of time of progression of chronic 
renal failure to end stage renal failure (ESRF) is very variable.  Early intervention may slow or halt the 
progression of chronic renal failure (CRF)9,10.  Key factors leading to the development of chronic renal 
failure (see Table 1) are: 
 
• Diabetic nephropathy; 
• Hypertensive vascular disease; and  
• Glomerular disorders. 
 
Regular assessment of at risk patients is important.  Persistent high blood pressure and heavy 
proteinuria are strong predictors of progression of chronic renal failure.  The use of good control of 
blood pressure lowering, good diabetes management, ACE inhibition and the avoidance of nephrotoxins 
may slow the decline of renal function11. 
 
Table 1: Causes of End Stage Renal Failure (ESRF) for new adult patients 2002 for England & Wales4 
      
% of new patients aged Cause of End Stage Renal Failure 
< 65 65 &+ 
Uncertain aetiology (Glomerulonephritis unproven)  17.5% 26.5%
Glomerulonephritis      13.5% 6.5%
Pyelonephritis      6.7% 6.3%
Diabetes        20.4% 14.5%
Renal vascular disease 2.8% 11.2%
Hypertension       5.1% 5.9%
Polycystic kidney     9.9% 3.0%
Other       14.4% 12.6%
Not recorded      9.6% 13.6%
Source: UK Renal Registry, 2003. 
  
Ethnicity 
 
Renal disease is more common in people of Asian and African Caribbean decent with acceptance rates to 
renal replacement therapy which are four times higher than in Caucasians12,13. 
 
Age and sex 
 
There is a steep rise in acceptance on to renal replacement therapy with age12.  Much of the increase in 
RRT over the last 20 years is due to the increased use of RRT in the over 65 population14,15.  The 
increase in age of patients will lead to an associated increase in co-morbidity.  Incidence of RRT is 
higher in men compared to women, with a ratio of about 1.5:12. 
 
Deprivation 
 
Incidence of RRT appears higher in more deprived areas (using Townsend score)4.  In part, this may be 
due to patients on RRT from ethnic minorities being from more deprived areas.  Patients from the 
 4
deprived areas are younger, have more co-morbid conditions, and have poorer 1 year survival which can 
be explained by cardiovascular co-morbidity. 
 
Renal service commissioning 
 
Services for renal disease are one of the agreed national specialised services and are therefore subject 
to special commissioning arrangements.  In the North East & Cumbria, commissioning for renal services 
is undertaken by a Regional Commissioning Group and takes into account the national definition of renal 
specialised services16.  All nephrology including end stage renal failure (ESRF), acute renal failure (ARF), 
general nephrology and renal related surgery should be included. 
 
Options for treatment 
 
There are three main types of renal replacement therapy (RRT) for the treatment of end stage renal 
failure (ESRF).  These are:  
 
• Transplantation; 
• Haemodialysis; and 
• Peritoneal dialysis. 
 
Transplantation 
 
The preferred option for the majority of patients is transplantation, which when successful provides a 
good quality of life without the need for dialysis.  Organ donation is from two principle sources, live 
related donors and donations from people who have died.  The majority of the cadaver donations are 
from heart beating donors where there is brain stem death.  More recently a non heart beating donor 
programme has been developed; in these cases the kidneys have to be retrieved and transplanted 
within 24 hours.  There is a shortage of organs for transplantation.  Transplantation is likely to be less 
suitable for patients with significant co-morbidity, and with a likely increase in co-morbidity may be 
unsuitable in a higher proportion of patients in future years. 
 
Haemodialysis 
 
Haemodialysis involves removing toxic products by attachment of dialysis equipment to the blood 
circulation of the patient and dialysing the blood.  Current good practice is to offer haemodialysis three 
times a week.  The process takes several hours, and is based in general in haemodialysis units.  A small 
number of patients have home haemodialysis machines. 
 
Peritoneal dialysis 
 
Peritoneal dialysis can be undertaken at home and is preferred by some patients.  Patients do require 
some residual renal function for peritoneal dialysis.  With an increasing proportion of elderly patients and 
patients with co-morbidity likely in future, a lesser proportion may be suitable for peritoneal dialysis.  
Continuous ambulatory peritoneal dialysis is now being replaced with automated peritoneal dialysis, 
which may be undertaken overnight. 
 
While an increasing elderly and co-morbid population will increase the overall demand for RRT, the 
increased incidence of co-morbidity is likely to increase the proportion of haemodialysis required. 
 
Erythropoietin 
 
Erythropoietin is used in ESRF to treat anaemia. It is administered either subcutaneously or 
intravenously.  It is used both while on dialysis and pre-dialysis.  It is expensive. 
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Services in the North East & Cumbria for renal disease 
 
There are four Renal Units in the North East & Cumbria as follows: Newcastle, Middlesbrough, 
Sunderland, and Carlisle.  Each unit also has one or more satellites working in association with the unit. 
 
Table 2: Renal Units and their satellites serving the North East & Cumbria, 2004 
 
Renal Unit Unit Hospital Satellite(s) 
Newcastle Freeman Hospital Royal Victoria Infirmary 
A satellite is planned for Wansbeck 
General Hospital  
 
Sunderland Sunderland Royal Hospital University Hospital of North Durham 
 
Middlesbrough James Cook University Hospital Darlington Memorial Hospital 
North Tees University Hospital 
 
Carlisle Cumberland Infirmary Cockermouth Hospital 
 
Source: Renal Units in the North East & Cumbria, 2004. 
 
Satellite units also undertake haemodialysis, but patients who are unwell are dialysed at the main unit in 
each case.  Satellite units are fully staffed with haemodialysis staff but in general, have no on site 
specialist renal physicians. 
 
Table 3: Prevalent cases of Renal Replacement Therapy (RRT) in Renal Units in the North East & 
Cumbria, 31st December 20024 
 
Number of patients Renal 
Unit 
Estimated 
Catchment 
Population 
(millions) 
Dialysis Transplant Total RRT 
Newcastle 1.31 189 465 654
Sunderland 0.34 127 129 256
Middlesbrough 1.00 242 280 522
Carlisle 0.36 85 85 170
Source: UK Renal Registry, 2003. 
 
Table 4: New adult patients accepted onto Renal Replacement Therapy, 2002 for Renal Units in the 
North East & Cumbria4 
 
Renal 
Unit 
Estimated 
Catchment 
Population 
(millions) 
Number of 
Patients 
Rate per 
million 
Newcastle 1.31 105 80
Sunderland  0.34 56 165
Middlesbrough 1.00 112 112
Carlisle 0.36 29 81
Source: UK Renal Registry, 2003. 
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Data on renal disease 
 
The UK Renal Registry 
 
The UK Renal Registry is registered as a charitable activity.  It was initially set up by the Renal 
Association, with support from the Department of Health, the British Association of Paediatric 
Nephrologists and the British Transplant Society.  It is now funded primarily by individual Renal Units 
who pay an annual fee of £12 per patient for registration.  The Registry reports that this method of 
funding enables them to maintain a level of independence17. 
 
The UK Renal Registry provides the collection and analysis of standardised data on the incidence, clinical 
management and outcomes of renal disease and acts as a source of comparative data, for audit, 
benchmarking, planning, clinical governance and research.  Data are collected quarterly by automatic 
downloading from Renal Unit databases. 
 
Current functions of the UK Renal Registry are to: 
 
• Collect demographic and descriptive data for comparison and planning; 
• Facilitate comparative audit by means of a carefully defined data set; 
• Collect data on indicators of quality of care to facilitate audit against recommended national 
standards, improved care, and identification of good practice; 
• Produce national and local outcome data; and 
• Publish Annual Reports to allow comparative audit of facilities, patient demographics, quality of 
care and outcome measures. 
 
At present, the data concentrates on renal replacement therapy, including transplantation.  At a later 
date the data will include other forms of treatment of renal disease.   
 
The UK Renal Registry, where possible, is starting to provide population data on incidence and 
prevalence.  This is currently being produced at former Health Authority level.  As the service is being 
commissioned as a specialised service, data are not required at individual PCT level. 
 
Not all Renal Units are as yet returning data to the UK Renal Registry.  At the end of 2002, about 80% 
of the UK was covered by the Registry and by the end of 2003, 90% coverage will have been achieved;   
all remaining Renal Units in the UK were considering participation in the Registry18.  Until such time as 
all units are actively participating in the UK Renal Registry, gaps will remain in the data.  However, the 
Renal Registry is a valuable source of data to support the commissioning of renal services; its value will 
increase as its coverage improves. 
 
The UK Renal Registry provides data for participating Renal Units, NHS Trusts, and commissioners of 
care.  The development of the Registry is open to influence by all interested parties including clinicians, 
trusts, commissioning authorities, and patient organisations.  
 
UK Renal Registry data in the North East & Cumbria 
 
The following Centres have for some time been participating in the UK Renal Registry: Middlesbrough 
(James Cook University Hospital), Sunderland (Sunderland Royal Hospital), and Carlisle (Cumberland 
Infirmary).   
 
Newcastle (Freeman Hospital) joined the UK Renal Registry in 2001.  Initially there were problems with 
data quality and validity in Newcastle, but these have now been resolved.  Data for 2001 were found to 
be of insufficient quality to be included in the UK Renal Registry’s 2002 report2; data for 2002 were of 
the quality required for inclusion in the 2003 report4. 
 
Tables 5-9 provide a summary of data for the North East & Cumbria provided by the UK Renal Registry. 
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Table 5: Prevalence of Renal Replacement Therapy (RRT), 1998-2002 by former Health Authority areas 
in the North East & Cumbria 4 
 
  Prevalence (Rate per million population) Former Health Authority 
area 1998 1999 2000 2001 2002 
Northumberland n/a n/a n/a 207 604
Newcastle & North Tyneside n/a n/a n/a 232 574
Gateshead & South Tyneside n/a n/a n/a 280 600
Sunderland 431 438 452 489 558
County Durham & Darlington 336 344 393 466 579
Tees 466 482 518 546 561
North Cumbria 485 501 504 542 526
Source: Renal Registry, 2003. 
 
Low prevalence for County Durham & Darlington and Sunderland Health Authorities before 2002 reflects 
the lack of data from Newcastle which serves some parts of County Durham and Sunderland.  Problems 
with data quality from the Newcastle Renal Unit resulted in severe undercounting for 2001 which have 
since been resolved4; it will be interesting to see if prevalence figures for Northumberland, Newcastle & 
North Tyneside, and Gateshead & South Tyneside increase further when figures for 2003 are released.   
 
Table 6: Prevalence of Renal Replacement Therapy (RRT), 31st December 2002 by former Health 
Authority areas in the North East & Cumbria 4  
  
 Dialysis Transplant All RRT Former Health 
Authority area Total 
pop. 
Number Rate per 
million 
Number Rate per 
million 
Number Rate per 
million 
Northumberland 309,600 74 239 113 365 187 604
Newcastle & 
North Tyneside 470,100 102 217 168 357 270 574
Gateshead & 
South Tyneside 353,500 84 238 128 362 212 600
Sunderland 292,300 61 209 102 349 163 558
County Durham & 
Darlington 607,800 154 253 198 326 352 579
Tees 556,300 131 235 181 325 312 561
North Cumbria 319,300 79 247 89 279 168 526
Source: Renal Registry, 2003. 
 
Prevalence of RRT varied between 342 and 930 per million population in England and Wales in 2002; the 
estimated England average was 615 per million population and the estimated UK average was 626 per 
million population4. 
 
Table 7: Incidence of Renal Replacement Therapy (Acceptance rate onto RRT) in adults, 1998-2002 by 
former Health Authority areas in the North East & Cumbria 4 
 
Incidence (Acceptance rate per million population) Former Health Authority 
area 1998 1999 2000 2001 2002 
Northumberland n/a n/a n/a n/a 77.5
Newcastle & North Tyneside n/a n/a n/a n/a 89.3
Gateshead & South Tyneside n/a n/a n/a n/a 101.8
Sunderland 51.3 85.5 82.1 88.9 95.8
County Durham & Darlington 100.4 74.0 72.4 75.7 98.7
Tees 107.9 91.7 82.7 93.5 116.8
North Cumbria 125.3 72.0 68.9 78.3 94.0
Source: Renal Registry, 2003. 
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Low incidence rates for County Durham & Darlington and Sunderland Health Authorities before 2002 
reflect the lack of data from Newcastle which serves some parts of County Durham and Sunderland.  
Additionally, it will be interesting to see if incidence figures for Northumberland, Newcastle & North 
Tyneside, and Gateshead & South Tyneside increase when figures for 2003 are released.   
 
The rate of acceptance on to treatment in end stage renal failure (ESRF) in the UK has been less than in 
Europe for some years.  The level of treatment for ESRF in the UK has increased in recent years14,18. The 
number of renal units has remained fairly constant; the increase has been enabled through an increase 
in number of haemodialysis stations, an increase in the number of shifts, and the development of 
satellite units18.  The rate of acceptance (incidence) may have stabilised, but the prevalence is increasing 
as survival on RRT increases. 
 
Table 8: Incidence of Renal Replacement Therapy (Acceptance rate onto RRT) in adults, 2002 by former 
Health Authority areas in the North East & Cumbria4 
 
Former Health Authority area Population Number of 
Patients 
Rate per 
million 
Northumberland 309,600 24 77.5
Newcastle & North Tyneside 470,100 42 89.3
Gateshead & South Tyneside  353,500 36 101.8
Sunderland 292,300 28 95.8
County Durham & Darlington 607,800 60 98.7
Tees   556,300 65 116.8
North Cumbria 319,300 30 94.0
Source: Renal Registry, 2003. 
 
The estimated England average incidence was 98 per million population and the estimated UK average 
incidence was 101 per million population4.  Incidence rates of RRT for adults varied between 58.0 and 
175.4 per million population in 2002 for former English health authority areas. 
 
Table 9: Unadjusted survival at 1 year of new patients with end stage renal failure (ESRF), 2001 cohort 
for England & Wales4  
 
Age Group % survival at 1 year 
18-34 97%
35-44 95%
45-54 91%
55-64 80%
65-74 70%
75-84 66%
85+ 49%
Source: Renal Registry, 2003. 
 
One year survival with ESRF, predictably, demonstrates a decline with increasing age. 
 
Study Findings 
 
The study identified 6 issues which are likely to be key to the implementation of the full Renal NSF.  
These were as follows: 
 
1. Data collection. 
2. Service planning and commissioning: 
• Predicting future need; 
• Specialised commissioning;  
• Taking account of population factors; 
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3. Staffing: 
• Consultant staffing; 
• Staffing of haemodialysis; 
• Staff mix. 
4. Care pathways: 
• Screening in primary care; 
• Guidance on referral from primary care;  
• Erythropoietin pre-dialysis;  
• Pre-dialysis counselling;  
• Vascular access. 
5. Patient access: 
• To renal replacement therapy;  
• To outpatient facilities;  
• During holidays;  
• Patient transport. 
6. Transplantation: 
• Equity; 
• Ethnicity; 
• Donor organs; 
• Time from harvest to transplant; 
• Theatre access. 
 
These issues are discussed in more detail below. 
 
1. Data collection 
 
Adequate data should be returned to the UK Renal Registry.  Data collection needs to be 
sufficiently funded.   
 
Data collection across the North East & Cumbria concerning patients with end stage renal failure (ESRF) 
is now standardised to collect the data set required by the UK Renal Registry.  This includes basic 
demographic data together with a comprehensive data set covering type of treatment, biochemical 
parameters relating to treatment, and co-morbidity.  This data set is extremely comprehensive and 
included data items are well defined, although in this study some anxiety about definitions of co-
morbidity was expressed by clinicians. 
 
Data collection is funded by the Renal Units paying a registration fee for each patient.  Comprehensive 
analyses are produced by the UK Renal Registry on an annual basis.  This report includes 
epidemiological data such as the uptake of RRT as well as information on quality indicators. 
 
Data collection in Renal Units has developed in an ad hoc manner and funding for this is often not 
clearly identified.  Units varied in their use of audit or review of data to assess their service provision. 
 
2. Service Planning and Commissioning  
 
Future prediction of need 
 
Provision of renal replacement therapy (RRT) was felt to be reasonable, with a view that the North East 
& Cumbria had historically been fairly well provided for.  It was generally thought that the incidence of 
end stage renal failure was either plateauing or continuing to increase, but was not declining.  Local and 
national data supported this view.  Even where the number of new cases was not thought to be 
increasing, improved survival means that the prevalence of RRT is increasing. 
 
 10
The UK acceptance rate onto renal replacement therapy (RRT) was 20 per million population in 1980 
rising to 101 per million population in 20014.  Prediction modelling undertaken by the UK Renal Registry 
suggests an increase in the numbers of patients on RRT for the next 20 years, when the numbers should 
stabilise19. 
 
Specialised commissioning 
 
The service should be commissioned as a specialised service on a ‘regional’ basis.  PCTs will need 
to ensure they are able to implement the Regional Commissioning Group’s recommendations. 
 
There is a Regional Commissioning Group for renal services in the North East & Cumbria.  This includes 
Trust clinicians and managers together with commissioners.  Overall, clinicians felt that this was an 
effective group.  However, the group does have a limited role, with little (or no) consideration of primary 
care issues.  The group was also formed for a defined period of time, this being for about 1 further year. 
 
Population factors 
 
The known ageing population is responsible for most of the increase in uptake in RRT.  Adequate 
access to renal expertise for this cohort of patients is required.  Patients could be referred to renal 
medicine or to physicians for the elderly. 
Levels of renal disease are higher in people of Asians and African Caribbean decent.  This has a 
considerable effect on the level of RRT required in areas with a high density of these populations. 
 
Clinicians had mixed views about the most appropriate route of referral for elderly patients with renal 
disease.  Options include only using renal physicians or some referral to elderly medicine.  In general it 
was felt important that such patients had access to a specialist although this could be to a geriatrician or 
physician with an interest in renal medicine.  Clear links between such services would need to be in 
place. 
 
There is a predominantly Caucasian population in the North East & Cumbria, but there are major issues 
elsewhere in the country with an increased requirement for RRT in African Caribbean and Asian 
populations. 
 
Increasing incidence of diabetes in the population will inevitably lead to an increased requirement of 
RRT. 
 
3. Staffing 
 
Consultant staffing levels 
 
The balance of the number of renal consultants and associated junior staff compared to patient 
population is important in ensure an appropriate service is in place. 
 
Table 10: Consultant staffing levels at Renal Units in the North East & Cumbria, 31/01/04 
 
 Newcastle Middlesbrough Sunderland Carlisle 
Number of Consultants 5 5 4 2 
Whole time equivalents 4 4 3.5 1 
Source: Renal Units in the North East & Cumbria, 2004. 
 
Consultant numbers only are shown, due to the complexities of junior medical staff numbers.  Workload 
varied dramatically between Renal Units.  This was influenced considerably by varying general medicine 
workloads; this had quite an impact on ‘actual’ nephrology time.  All consultants were experiencing some 
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difficulties with workload.  Interview findings were a view that Newcastle has poor consultant staffing 
levels, while Middlesbrough has difficulty sustaining the wide network of outpatient clinics it runs. 
 
Despite providing a service to a larger population, Newcastle had the same consultant establishment as 
Middlesbrough.  This was however substantially compensated for by Newcastle’s much higher level of 
middle grade cover.  Middlesbrough appeared to be especially short of middle grade cover. 
 
Availability of trained staff to run haemodialysis service 
 
Historically haemodialysis units have been fully staffed by nurses. In more recent times some 
services have utilised technicians to provide some dialysis care.  
 
No local problems with recruitment were reported, although staff retention was sometimes problematic.  
 
Staff mix 
 
Newcastle, Middlesbrough and Carlisle use nurses to staff their haemodialysis units, with some nurse 
assistant support.  Sunderland makes a greater use of technicians, with a nurse to technician ratio of 
60:40.  Nurses have a wider range of skills, being able to plan and evaluate care as well as deliver care; 
technicians only deliver care.  All the units had developed nurse practitioners or nurse specialists in some 
areas, but these varied widely.  Examples included nurse practitioners in a clinical investigations unit, a 
transplant facilitator, pre-dialysis nurses, and an anaemia co-ordinator.  Most interesting was the use of 
a Nurse Consultant in the Durham satellite unit. 
 
4. Care pathways 
 
Screening in primary care 
 
Appropriate screening in primary care will improve early diagnosis of chronic renal failure. 
 
Patients at high risk of developing renal problems are those with a history of renal disease and those 
with diabetes.  At increased but lesser risk are those with hypertension and those with CHD.  These 
cohorts of patients should have blood urea and electrolytes undertaken at diagnosis and thereafter 
probably on an annual basis.  The use of urine testing for protein in this group is also important. 
 
Primary care referral guidance 
 
Guidelines should be in place to ensure appropriate patients are referred early to renal medicine. 
 
Consultants felt that early diagnosis was important and that they were able to reduce progression to end 
stage renal failure.  However, there is very little existing guidance about referral from primary care; 
most notably when to refer patients was not the subject of guidelines.   
 
Overall consultants felt that referral of patients with a creatinine of 150 µmol/l or higher should be 
referred for a renal opinion, but were concerned about the numbers this would generate and their 
capacity to meet demand in such cases. They had not considered how such an increase in demand 
might be met.  It was unclear whether all patients with a high creatinine needed to be seen by a renal 
physician in out-patients or whether a letter based opinion or alternative service could suffice in some 
cases. 
 
 12
Erythropoietin pre-dialysis 
 
Shared care protocols should be in place concerning the use of erythropoietin in primary care. 
 
Access to erythropoietin pre-dialysis is an important component of modern renal medicine.  
Erythropoietin is administered either subcutaneously or intravenously.  If erythropoietin is not available 
to the patient in primary care, or the patient is unable to self administer, they may have to travel to the 
Renal Unit for injections. 
 
Shared care protocols between GPs and Consultants were in place in Newcastle, Sunderland and Carlisle, 
but not in Middlesbrough.  It is, however, unclear if shared care protocols had been adopted by every 
related PCT.  Some localised problems were reported.  Some consultant nephrologists perceived that the 
major barrier to the implementation of shared care protocols was funding.  There did appear to be 
issues with funding for erythropoietin being allocated to Trusts leading to perceived difficulties 
transferring care, where appropriate, to primary care.  With PCTs such barriers in theory ought to be 
more easily overcome, but historic patterns of care may confound this.  
 
Pre-dialysis counselling 
 
Pre-dialysis counselling (where appropriate), is important to ensure patients are able to make an 
informed choice between modes of dialysis. 
 
Newcastle, Middlesbrough and Carlisle Renal Units are able to offer pre-dialysis counselling.  Sunderland 
Renal Unit cannot offer formal counselling, but patients are seen by a nurse pre-dialysis. 
 
Vascular access  
 
Vascular access is required for haemodialysis.  An arteriovenous fistula is normally used.  If there 
are delays in providing proper vascular access patients may have to be dialysed through temporary 
neck lines.  This carries infection (and other) risks. 
 
The availability of adequate vascular access is dependant on surgeon time and theatre time.  Vascular 
access surgery can in general be undertaken under regional anaesthetic; more complex cases require 
general anaesthetic.  Neck lines are often inserted in the radiology department and this can be quite a 
significant workload.  The accessibility of provision of vascular access varies greatly between Renal 
Units.  
 
Newcastle 
 
Vascular access is undertaken by the transplant surgeons who hold weekly vascular access clinic.  The 
service is currently provided by a single surgeon, although there is funding for a further surgeon to 
undertake some of the procedures.  The waiting time is short – about 3 weeks.  Although there are 
three lists a week there are constraints on theatre time, and available time is insufficient.  Funding is 
available to improve the local service (possibly using a staff grade doctor).  There is no dedicated 
radiology input in outpatients, and poor access to radiology services.  It was felt that this was primarily 
due to inadequate numbers of radiology staff.  In addition it was felt that links to radiology could be 
improved. 
 
Sunderland 
 
A hospital practitioner does one list a week of fistulas.  Complex cases are referred on to the vascular 
surgeons.  A weekly clinic is held by a vascular surgeon.  Patients will usually be operated on within the 
same week, complex cases are done under general anaesthetic in main theatres. 
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Middlesbrough 
 
Vascular access is undertaken by vascular surgeons.  Access is generally good with a waiting time of 2-3 
weeks.  However, there was not a dedicated service and it was felt a dedicated link to vascular surgery 
would help improve the service. 
 
Carlisle 
 
The vascular surgeons have recently taken on this work.  There is no dedicated time for this service but 
there are 2 vascular surgeons involved.  No problems were reported with the service apart from a lack of 
beds. 
 
5. Patient access 
 
Access to renal replacement therapy 
 
The provision of renal replacement therapy (RRT) should be adequate to allow patients to access 
haemodialysis locally.  Haemodialysis should be offered to patients three times a week. This has 
clear implication for patients travelling between home and the unit, and therefore there should be 
spare capacity so that patients can be offered the choice of unit. 
 
Table 11: Numbers of patients with ESRF on treatment at 31/01/04 by Unit and satellite 
 
Renal Unit 
and Satellite(s) 
No of 
haemodialysis 
stations 
No of 
haemodialysis 
slots 
No of 
patients 
on haemo-
dialysis 
No of 
patients on 
peritoneal 
dialysis* 
No of 
transplanted 
patients* 
Newcastle Renal Unit 
Freeman 19 134 134 42 549
RVI 17 83 70  
Sunderland Renal Unit 
Sunderland  20 120 83 17 143
Durham 12 48 29  
Middlesbrough Renal Unit 
Middlesbrough 20 + 8 temp 152 149 22 312
Darlington 13 74 74  
Stockton 0 0 0  
Home 3 3 3  
Carlisle Renal Unit  
Carlisle 14 56 62 19 85
Cockermouth 3 12 12  
Source: Renal Units in the North East & Cumbria, 2004 
 
Note: * figures presented are for the whole Renal Unit including satellites. 
 
All of the Renal Units in the North East & Cumbria work a 6 day week allowing cleaning time on the 7th 
day.  Three shifts a day is usual in Renal Units with two shifts in satellites.  Newcastle (Freeman) 
however, has 4 shifts a day with one late evening shift finishing about 2:00 a.m.  There was limited 
spare capacity at the time of the study. 
 
There is little or no spare capacity in Newcastle.  There is a shortage of space at present.  The 
Newcastle Renal Unit is planning developments including new and expanded facilities at the Freeman 
Hospital (due in 2005).  The satellite unit at the Royal Victoria Infirmary will then close.   
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There is no haemodialysis provision in Northumberland.  This is currently being reviewed and a satellite 
unit in Ashington (at Wansbeck General Hospital) is proposed.  There is some spare capacity in 
Sunderland, Middlesbrough and Carlisle. 
 
Access to outpatient facilities 
 
Patients should have access to outpatients locally, where possible. 
 
Table 12: Location of outpatient facilities 
 
Renal Unit Outpatients held in: 
Newcastle Newcastle (Freeman Hospital)  
 Newcastle (Royal Victoria Infirmary) 
 Gateshead (Queen Elizabeth Hospital) 
Middlesbrough Middlesbrough (James Cook University Hospital) 
 Stockton (North Tees University Hospital) 
 Northallerton (Friarage Hospital) 
 Hartlepool (Hartlepool University Hospital) 
 Darlington (Darlington Memorial Hospital)  
 Bishop Auckland (Bishop Auckland General Hospital) 
Sunderland Sunderland (Sunderland Royal Hospital) 
 Durham (University Hospital of North Durham) 
Carlisle Carlisle (Cumberland Royal infirmary) 
 Whitehaven (West Cumbria Hospital) 
Source: Renal Units in the North East & Cumbria, 2004 
 
The Middlesbrough Renal Unit has made considerable efforts to ensure local outpatients are provided in 
all surrounding District General Hospitals.  Outpatient access in Northumberland, North Tyneside, and 
South Tyneside is to hospitals in Newcastle, Gateshead and Sunderland. 
 
Holiday access 
 
Ideally all units should be able to accommodate patients from other areas of the country while on 
holiday in the area. 
 
Most of the Renal Units in the North East & Cumbria are able to offer holiday haemodialysis but this 
does depend on availability. 
 
Transport 
 
Patients attend for haemodialysis three times a week.  Transport needs to be as accessible and 
efficient as possible with minimum possible waiting times. 
 
Delays were felt to be responsible for quite a lot of patient distress.  All units felt that some aspects of 
the transport service could be improved.  Inflexible contracts with ambulance services mean that 
patients are sometimes disadvantaged. 
 
Newcastle 
 
Transport is provided by the ambulance service and some long delays were experienced. 
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Sunderland 
 
Transport was predominantly a car-based service, which was felt to work well.  Where an ambulance-
based service was used, waits could be long.  Difficulties were experienced with transport to outpatients 
and the rigid schedule of the ambulance service. 
 
Middlesbrough 
 
An ambulance-based service is used.  The transport in Middlesbrough was reported as being poor.  
There were particular problems with the timing of ambulances for outpatients. 
 
Carlisle 
 
Transport is provided by a car-based service; waits were felt to be reasonable.  No problems were 
experienced with early or late haemodialysis sessions. 
 
6. Transplantation 
 
There is a need to ensure equity of availability of transplantation.  Key factors influencing this are 
ethnicity, age and distance from transplantation centre.  
There is a shortage of organs and surgeons.  There is a particular shortage nationally of organs 
from non-Caucasian donors.  
 
The North East & Cumbria has a single service for transplantation based in Newcastle which also 
undertakes liver transplants.  The transplant co-ordinators are based in Newcastle.  It is hoped to 
employ a further transplant co-ordinator based in Sunderland.  There is a live donor co-ordinator based 
in Middlesbrough. 
 
Equity 
 
Clinicians from all the Renal Units felt they were being offered an equitable service from the transplant 
unit, this is confirmed by figures from the UK Renal Registry4. 
 
Ethnicity 
 
The North East & Cumbria has a predominantly Caucasian population. 
 
Donor organs 
 
There is a national shortage of donor organs.   
 
Cadaver organs 
 
The numbers of cadaver organs becoming available has been falling.  The average wait for a transplant 
in Newcastle is 388 days but the range is very wide. Newcastle has the lowest average wait in the 
country, the national average being 642 days (range 388-1,282 days). 
 
The non-heartbeating donor programme has run in Newcastle from 1998.  At present there are a 
number of other units in the UK implementing a similar service following promotion by UK Transplant.  
The non-heartbeating donor removals are undertaken by a single consultant surgeon.  These kidneys 
should have a cold ischemic time of 24 hours or less.  UK Transplant has increased the funding in order 
to increase number of junior surgeons in Newcastle; this will increase the availability of surgeons to do 
retrievals. 
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Live donors 
 
Newcastle uses two theatres when undertaking live transplants; this requires additional theatre space 
but this is thought to improve results for both donor and recipient.  The cold ischemic time is reduced by 
parallel, rather than sequential, operating.  Newcastle has a capacity to undertake 20 live related 
transplants a year.  They undertake the donor procedure laparoscopically where possible.  Newcastle is 
one of only three Units offering laparoscopic surgery at present and, in consequence, is getting some 
national referrals. 
 
Newcastle is a combined liver & kidney transplant unit. Liver transplants often take priority over live 
kidney transplants which means that a kidney transplant may be delayed, increasing the cold ischemic 
time. 
 
Time from harvest to transplant (cold ischemic time) 
 
The lower the cold ischemic time, the better the transplant survival.  Newcastle has a median cold 
ischemic time of 21 hours.  The national average is 19 hours.  The Newcastle service takes a longer time 
to book kidneys in.  Additionally, access to emergency theatres was also not ideal, both contributing to 
the length of cold ischemic time. 
 
Theatre access 
 
There is no dedicated emergency theatre for transplants - so kidney transplants have to fit in with other 
emergencies.  Dedicated theatre time would however have resource implications.  
 
 
Recommendations 
 
1. Data collection 
 
1a. Data collection 
 
All Renal Units should be required to return data to the UK Renal Registry, which collects a 
comprehensive standardised data set.  Individual units need to ensure that their data collection is valid 
and reliable.  While the coverage of the Registry continues to increase, it is still not complete for 
England.  Until data collection is comprehensive, population data reflecting the needs and treatment of 
geographic populations will be problematic.  Population data as currently produced by the UK Renal 
Registry may still be inaccurate for some parts of the country. 
 
Data for commissioners should be improved.  However, improvement is dependant on adequate local 
data being returned to the UK Renal Registry.  The UK Renal Registry should give consideration to 
producing data by PCT groupings other than former Health Authority boundaries where this is 
appropriate to the local service. 
 
Commissioners should examine data on uptake of renal replacement therapy and type of renal 
replacement therapy for their population and ensure uptake is appropriate to need. 
 
1b. Data funding 
 
While the current funding mechanisms for the UK Renal Registry offer a degree of independence, 
commissioners should explicitly identify funding for the UK Renal Registry in contracts. 
 
Data collection in Renal Units should also be explicitly funded through contracts.  Data access in 
outpatient departments should be reviewed and patient data should be fully accessible in all outpatient 
departments.  Proper data links to the main Renal Unit should be put in place.  One key component of 
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this is the provision of local electronic patient data so that up to date patient data (e.g., blood results) 
are available.  Data links to the main unit and to local pathology results are needed. 
 
At present the UK Renal Registry provides copies of its Annual Reports not only to Renal Units but also 
to PCTs.  This is quite costly and better use of resources might be made by providing PCTs with 
summary reports only with on-line access to the full report (http://www.renalreg.com/home.htm).  
 
2. Service planning and commissioning 
 
2a. Future prediction of need 
 
Local data are required to enable commissioners to examine potential trends.  This will not be resolved 
in all areas of the country until the UK Renal Registry achieves completes coverage. 
 
2b. Service commissioning group 
 
The existing Regional Commissioning Group in the North East & Cumbria is an essential means of 
ensuring that appropriate renal services are provided for the populations served by the region’s four 
Renal Units.  The Strategic Health Authorities and their PCTs need to ensure that a longer term remit is 
provided for this group. 
 
Individual Renal Units should be required (through the commissioning process) to audit their 
performance against the UK Renal Registry data. 
 
2c. Population factors 
 
The consequences of an ageing population and increasing incidence of diabetes need to be adequately 
considered when planning renal services. 
 
3. Staffing 
 
3a. Staffing levels 
 
Staffing level should be reviewed.  Additional clinical staff may be required, but use of innovative 
approaches, such as nurse practitioners or written referral mechanisms, may be possible solutions.   
 
Sufficient consultant staff should be in place to develop outpatients in areas currently poorly served.  
Equity in the provision of junior medical staff needs to be considered. 
 
3b. Staff mix 
 
Only one Renal Unit makes use of technicians in haemodialysis.  With a shortage of senior nurses it may 
be appropriate for all units to consider this in the future. 
 
The role of nurse specialists and nurse practitioners should be further developed.  The nurse consultant 
model used in the Durham satellite should be reviewed and developed more widely, where appropriate. 
 
4. Care pathways 
 
4a. Screening in primary care 
 
GPs should incorporate screening for urea, electrolytes and creatinine into their baseline screening 
protocols for diabetes, ischaemic heart disease and high blood pressure.  It is probably appropriate to 
incorporate this into the annual reviews of these patients, although the scientific basis for this is less 
clear.  Where creatinine is high, urine should be tested for protein in primary care. 
 
 18
4b. Primary care referral guidance 
 
Interview findings suggest that insufficient patients with a high creatinine (over 150 µmol/l) are 
currently being offered a renal opinion.  Some patients may be stable and can be managed in primary 
care.  Options include referral to specialist geriatrician, referral to renal medicine, and use of a 
diagnostic guideline to determine the need for renal input.   
 
Guidelines for referral from primary care should be developed and implemented. These should cover: 
 
• Types of patients to be referred; 
• Level of blood results where referral is needed; 
• List of information required. 
 
A review of hospital outpatient services is required to determine how such extra work load would be 
managed.  Options include a more innovative referral system aiming to identify those patients who 
require outpatient assessment through the use of a protocol, enabling stable patients to be managed in 
primary care, or using a protocol as the basis for developing a nurse-led service.   
 
The Regional Commissioning Group should work on the development of such a protocol and identify 
appropriate routes for implementation.  
 
4c. Erythropoietin in primary care 
 
Shared care guidelines for the use of erythropoietin in primary care should be in place in each Renal Unit 
and surrounding PCTs.  It is recommended that a shared care protocol is agreed by the Regional 
Commissioning Group and then adopted and implemented by each PCT, so that safe and efficient local 
care may be provided to patients. 
 
4d. Pre-dialysis counselling 
 
All units should offer pre-dialysis counselling.  The Sunderland Renal Unit should develop more explicit 
local counselling. 
 
4e. Vascular access 
 
Surgical links to renal medicine for the provision of vascular access are needed and should be more 
clearly defined in some Renal Units.  More use could be made of clinical specialists in association with 
vascular surgeons.  Much vascular access surgery only requires regional anaesthesia, rather than 
general anaesthetic.  Units should review their surgical links and work on the development of specialist 
teams. 
 
The surgical unit at Newcastle needs to ensure planned developments to increased staff numbers are 
implemented.  Links to radiology, the level of radiology input, and radiology staff mix should be 
reviewed in Newcastle. 
 
5. Patient access 
 
5a. Access to renal replacement therapy 
  
The Northumberland area has poor local dialysis provision and the development of a satellite unit 
planned for Wansbeck General Hospital in Ashington should be a priority.  If a further satellite is 
developed in the south of the region consideration should be given to whether this could be provided in 
the East Cleveland area. 
 
Newcastle should ensure implementation of plans so that all patients can be offered haemodialysis in 
day time hours, and only those patients who wish it should be on a shift finishing at 2.00 a.m. 
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5b. Access to outpatients 
 
The south of the region is well served by local outpatient facilities.  The northern part should be 
provided with more accessible local outpatients.  Poorly served areas at present include South Tyneside, 
North Tyneside, and Northumberland.   
 
Renal Units should review their provision of outpatients through the Regional Commissioning Group, and 
ensure more accessible provision is put into place. 
 
5c. Transport 
 
There are problems with delays to transport for some Renal Units.  Individual Renal Units should review 
their performance and identify the nature and length of delays and work with patients to examine how 
to improve the service. 
 
6. Transplantation (Newcastle only) 
 
6a. Donor organs 
 
The non-heartbeating donor programme needs to be further evaluated and developed as appropriate.  
Increased surgical input with more than one specialised surgeon is essential to maintaining the current 
services and planned developments. 
 
6b. Time from harvest to transplant 
 
The length of cold ischemic time should be reviewed, and the service provision examined to determine if 
it is possible to reduce it. 
 
6c. Theatre access 
 
Access to theatre for transplants should be improved.  This, however, requires consideration alongside 
other emergency services. 
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